通过激活CDKN1A-RB-E2F1通路,RC48诱导HER2表达结肠癌细胞的衰老
Jiaxue Wu1, Qianqian Li1, Xiangyu Cheng2
1Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Current cancer drug targets
|July 17, 2025
概括
RC48是一种抗HER2抗体-药物联合体,通过诱导细胞衰老,在结肠癌中显示出抗瘤作用. 这种机制通过增加CDKN1A表达的介导,在HER2-高和HER2-低瘤中有效.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- RC48是一种抗HER2抗体-药物结合物,在结肠癌中具有已证明的抗瘤活性.
- 该药物在具有高和低HER2表达的瘤中表现出有效性.
- 了解RC48在结肠癌中的机制对于优化其临床应用至关重要.
研究的目的:
- 研究RC48在结肠癌细胞中的潜在抗瘤机制.
- 探索 HER2 表达水平在 RC48 疗效中的作用.
- 确定参与RC48治疗效果的关键分子通路.
主要方法:
- 基于细胞的测试 (透孔,流细胞计) 用于评估RC48对HT29 (HER2-高) 和SW480 (HER2-低) 结肠癌细胞的影响.
- 蛋白质组分析被用来识别受RC48治疗影响的蛋白质和途径.
- 使用β-Galactosidase染色和ELISA对与衰老相关的分泌表型因子进行验证衰老.
- 生物信息学分析将蛋白质表达与HER2水平相关联.
主要成果:
- RC48抑制了HT29和SW480结肠癌细胞的生长.
- 蛋白质组和生物信息学分析显示,RC48在两个细胞系中显著增强了CDKN1A的表达.
- RC48治疗促进了细胞衰老,由增加的β-Galactosidase活性和衰老相关因素的分泌物证明.
- 过度表达单独的CDKN1A抑制了结肠癌细胞的生长,这表明它的关键作用.
结论:
- 在结肠癌中,CDKN1A介导的细胞衰老被确定为RC48的关键抗瘤机制,无论HER2的表达水平如何.
- 这一发现为RC48.8的临床应用提供了新的理论基础.
- 需要进一步的体内和临床研究来验证这些发现,并阐明CDKN1A和HER2之间的调节关系.
关键词:
这是一种ADC药物.这就是CDKN1A.在HER2中,HER2是HER2.RC48 RC48 RC48 RC48 RC48 RC48 RC48 RC48 RC48 RC48 RC48 RC48 RC48 RC48 RC48 RC48细胞衰老 细胞衰老结肠癌是什么意思结肠癌是什么意思更多相关视频
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
8.3K
08:54An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
14.1K
相关概念视频
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Negative Regulator Molecules
36.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
36.1K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
